Caribou Biosciences (CRBU) EBT Margin (2020 - 2026)
Caribou Biosciences (CRBU) recorded EBT Margin of -1690.39% in Q2 2026, up 93.56 percentage points from -1783.95% a year earlier but down 594.02 percentage points from the prior quarter.
Caribou Biosciences (CRBU) EBT Margin (2020 - 2026) Analysis & Trends
On a TTM basis, Caribou Biosciences' EBT Margin came in at -1090.90% as of Jun 30, 2026, up 746.66 percentage points year-over-year; for FY2025, it came in at -1332.33%, up 159.70 percentage points from FY2024.
- Annual EBT Margin has a five-year change of -1040.07 percentage points (FY2020 to FY2025).
- Across earlier years, EBT Margin came in at -1492.04% in FY2024 (-1196.54 pp), -295.49% in FY2023 (+421.79 pp), -717.28% in FY2022 (-23.37 pp) and -693.92% in FY2021 (-401.65 pp).
- Quarterly EBT Margin has ranged from -1893.87% in Q1 2024 to -61.84% in Q3 2023 over the past five years.
- On a year-over-year basis, EBT Margin has increased for four consecutive quarters, with an average year-over-year change of -72.81 percentage points over the last eight quarters.
- Peak year-over-year performance for EBT Margin in the last five years was a gain of 1149.72 percentage points in Q4 2025, against a drop of 1827.39 percentage points in Q3 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at -1096.37% (Q1 2026), -721.97% (Q4 2025) and -1337.58% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 40.25% |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 25.18% |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | -4.11% |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 27.53% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -131.41% |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | -4.34% |
| 10 | Caribou Biosciences | 56.06 Mn | -460.48 Mn | - | -1,690.39% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,690.39% |
| Mar 31, 2026 | -1,096.37% |
| Dec 31, 2025 | -721.97% |
| Sep 30, 2025 | -1,337.58% |
| Jun 30, 2025 | -1,783.95% |
| Mar 31, 2025 | -1,823.76% |
| Dec 31, 2024 | -1,871.69% |
| Sep 30, 2024 | -1,889.23% |
| Jun 30, 2024 | -1,255.80% |
| Mar 31, 2024 | -1,893.87% |
| Dec 31, 2023 | -1,052.33% |
| Sep 30, 2023 | -61.84% |
| Jun 30, 2023 | -875.31% |
| Mar 31, 2023 | -888.52% |
| Dec 31, 2022 | -828.22% |
| Sep 30, 2022 | -803.42% |
| Jun 30, 2022 | -678.22% |
| Mar 31, 2022 | -782.77% |
| Dec 31, 2021 | -709.57% |
| Sep 30, 2021 | -527.38% |
Caribou Biosciences EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=CRBU&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "CRBU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=CRBU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();